The Division of Computational and Molecular Prevention of the DKFZ, in collaboration with the Translational Molecular Imaging in Oncologic Therapy Monitoring Unit, invites applications for a postdoctoral researcher to join an interdisciplinary research program within the PRELUNG study, focusing on early lung cancer detection and biological characterization of pulmonary nodules. The position combines cutting-edge multimodal data analysis with patient-centered translational research, including a novel co-design initiative on the return of molecular and imaging data to study participants.
Project Background
Pulmonary nodules from hundreds of patients are being collected and biopsied as part of a prospective imaging study. Up to 40 FFPE biopsy samples will be analyzed using spatial transcriptomics and mutREAD DNA sequencing, enabling integrative analysis of spatial gene expression, tissue architecture, and genomic alterations at early stages of lung carcinogenesis. The postdoctoral researcher will play a central integrative role, leading unbiased computational analyses, biological interpretation, and biomarker discovery in close collaboration with clinicians, pathologists, and technology experts across multiple research groups.
Your Tasks
Scientific & Computational Responsibilities
Translational & Collaborative Responsibilities
Patient Engagement & Return-of-Data Work Package
Your Profile
Given the dual scientific and participatory nature of the project, exceptional interpersonal skills are a core requirement. The successful candidate will demonstrate:
Applicants are encouraged to highlight concrete evidence of these skills (e.g. patient-facing research, public engagement, teaching, facilitation, or interdisciplinary leadership).
You can look forward to
Application
Interested applicants should submit the following documents via our online application tool:
We are convinced that an innovative research and working environment thrives on the diversity of its employees. Therefore, we welcome applications from talented people, regardless of gender, cultural background, nationality, ethnicity, sexual identity, physical ability, religion and age. People with severe disabilities are given preference if they have the same aptitude.
The German Cancer Research Center (DKFZ) stands for excellent science, groundbreaking innovations, and a clear mission: researching for a life without cancer.
As the largest biomedical research institution in Germany and a member of the Helmholtz Association of German Research Centres, we are dedicated to advancing cancer research. Our scientists study the origins of cancer, identify risk factors, and develop strategies to prevent people from developing the disease. They create innovative approaches to diagnose tumors more precisely and treat cancer patients more effectively.
Our mission is to significantly decrease new cancer cases and cancer deaths through transformative research, education of the next generation of leaders and seamless transfer of our results into the health system, society, and innovative products.
A future where groundbreaking discoveries empower a life without cancer, foster healthier societies and inspire a global commitment to prevention, early detection and treatment. Research for a life without cancer.
Images
Image 1 (top left): DKFZ banners on campus
Image 2 (top right): DKFZ Research Scientist
Image 3 (bottom left): DKFZ Heidelberg campus
Image 4 (bottom right): Heidelberg, Germany